"UPMC Stroke Institute is a neurologist located in Pittsburgh.Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, UPMC Stroke Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Stroke Institute" #1 collaborator was "Astellas Pharma US, Inc." with 2 trials as a collaborator, "University of Calgary" with 1 trials as a collaborator and "University of Pittsburgh Medical Center" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Stroke Institute" are "Acute Ischemic Stroke" (1 trials), "Cerebrovascular Accident" (1 trials), "Intracerebral Hematoma" (1 trials), "Ischemic Stroke" (1 trials) and "Stroke, Acute" (1 trials). Many other conditions were trialed in "UPMC Stroke Institute" in a lesser frequency.

Most popular intervention types in "UPMC Stroke Institute" are "Drug" (3 trials), "Device" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Intracerebral catheter placement" (1 trials), "Medical Management" (1 trials), "Nerinetide" (1 trials), "Placebo" (1 trials) and "Robot-assisted intracerebral catheter" (1 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Stroke Institute" are 5 trials for "All" genders.

Currently, there are NaN active trials in "UPMC Stroke Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in UPMC Stroke Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Stroke Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".